21.05.2024 07:12 - About Us - Mediadaten - Imprint & Contact - succidia AG
Scientist > Johannes Flamm

Johannes Flamm

// studied pharmacy in Freiburg and has been a doctoral candidate since 2015 in the Prof. Katharina Zimmermann lab in the Institute of Pharmaceutical Biotechnology at Biberach University of Applied Sciences

// His thesis topic is “The intranasal nose-to-brain transport mechanism and approaches for the controlled application of active ingredients by means of intranasal delivery”

Contact: laborundmore@succidia.de

How biopharmaceutical drug substances use the nose as a pathway to the brain

Behind the doorman’s back - von Johannes Flamm, Stefan Carle, Martina Stützle, Prof. Dr. Katharina Schindowski Zimmermann

According to WHO estimates, over 1 billion people worldwide suffer from disorders of the central nervous system (CNS). Some of the most familiar are Alzheimer’s, Parkinson’s and multiple sclerosis. Although they have long been the focus of research, effective pharmacotherapies are still unavailable for many of these diseases. What is it about CNS disorders that makes it especially difficult to develop drug products that target pathophysiological...